Short Term Trading Week Starting: 23 Jul, page-39

STTCOMP LSH, TA Long

Lifespot Health Ltd is a medical diagnostic and telemonitoring technology company focusing on the Australian and European markets. Medtech involves diagnostic and monitoring, e.g blood glucose for diabeties + medicinal cannabis 'vape' device near prototype launch. Has revenue at just over $500k per year with revenue pipeline.

SP at close 23/7/18: 12.5c (52w range 10.5c-19.5c)
SoI: 75m (note that there are 47.25m FPO quoted securities with 27.69m FPO shares in escrow, see last 3B here)
T20: T20 hold 64% so tight register
MC: $9.375m (or $5.9m based on quoted securities)
Cash (est): $3.35m (based on $3.9m cash at 31/3 + revenue $170k less burn of $720k).
Debt: nil
EV: $6m (or $2.5m based on quoted securities).
Pres: https://www.asx.com.au/asx/statistics/displayAnnouncement.do?display=pdf&idsId=01984441
Potential four-week newsflow: Vape prototype launch, further revenue, med cannabis deal.

Relatively recent IPO, listed on 12 January 2017, fully subscribed IPO raising $8m at 20c issue price, with a valuation at IPO of $15m.

Large volume spike Friday, with some profit-taking today (it looked like most of the volume was a single seller exiting). Strong newsflow just around the corner, deals have been in the works for some time. Stock has found a base and has consolidated sufficiently given the small SoI and tight register.

On the first daily I've highlighted a couple of potential overhead supply points plus two overhead gaps that could be relevant to trading. Second daily chart shows the full picture since IPO. Third chart is the weekly to close Friday 20/7.